Literature DB >> 14506648

Discordancy for maternal floor infarction in dizygotic twin placentas.

Raymond W Redline1, Jie-Gen Jiang, Dinesh Shah.   

Abstract

Maternal floor infarction (also known as massive perivillous fibrin/fibrinoid deposition) is a rare and devastating pregnancy disorder associated with prematurity, fetal growth restriction, spontaneous abortion, and long-term neurologic impairment. Recurrence in multiple pregnancies is common. Little is known regarding either the pathophysiology or the management and treatment of patients at risk for recurrence in subsequent pregnancies. Most authors have emphasized maternal risk factors believed to act in a dominant fashion irrespective of fetal genotype. We report on dizygotic twins discordant for the development of placental maternal floor infarction and fetal growth restriction. The mother was a poorly controlled class C diabetic, and the onset of disease was coincident with the clinical onset of preeclampsia. This case demonstrates that fetal genotype, or some other factor specific to an individual fetoplacental unit, can lead to the differential expression of maternal floor infarction in dizygotic twins gestating in the same intrauterine environment.

Entities:  

Mesh:

Year:  2003        PMID: 14506648     DOI: 10.1016/s0046-8177(03)00288-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; James H Segars; Alan H DeCherney; M Cathleen McCoy; Chong Jai Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2015-04-20

2.  Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?

Authors:  Roberto Romero; Amy Whitten; Steven J Korzeniewski; Nandor Gabor Than; Piya Chaemsaithong; Jezid Miranda; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Reprod Immunol       Date:  2013-08-01       Impact factor: 3.886

Review 3.  [Massive perivillous fibrin deposition, chronic histiocytic intervillositis and villitis of unknown etiology: Lesions of the placenta at the fetomaternal interface with risk of recurrence].

Authors:  H Feist; T Blöcker; K Hussein
Journal:  Pathologe       Date:  2015-07       Impact factor: 1.011

4.  Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Authors:  Amy E Whitten; Roberto Romero; Steven J Korzeniewski; Adi L Tarca; Alyse G Schwartz; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

5.  Disorders of placental villous maturation in fetal death.

Authors:  Sunil Jaiman; Roberto Romero; Percy Pacora; Eunjung Jung; Gaurav Bhatti; Lami Yeo; Yeon Mee Kim; Bomi Kim; Chong Jai Kim; Jung-Sun Kim; Faisal Qureshi; Suzanne M Jacques; Offer Erez; Nardhy Gomez-Lopez; Chaur-Dong Hsu
Journal:  J Perinat Med       Date:  2020-04-01       Impact factor: 1.901

6.  One-Sided Chronic Intervillositis of Unknown Etiology in Dizygotic Twins: A Description of 3 Cases.

Authors:  Lotte E van der Meeren; Juliette Krop; Kyra L Dijkstra; Kitty W M Bloemenkamp; Emily F Cornish; Peter G J Nikkels; Marie-Louise P van der Hoorn; Manon Bos
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

7.  Fetal akinesia deformation sequence and massive perivillous fibrin deposition resulting in fetal death in six fetuses from one consanguineous couple, including literature review.

Authors:  Jill K Tjon; Phillis Lakeman; Elisabeth van Leeuwen; Quinten Waisfisz; Marjan M Weiss; Gita M B Tan-Sindhunata; Peter G J Nikkels; Patrick J P van der Voorn; Gajja S Salomons; George L Burchell; Ingeborg H Linskens; Bloeme J van der Knoop; Johanna I P de Vries
Journal:  Mol Genet Genomic Med       Date:  2021-10-12       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.